Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b

Clinical trial NCT03222167 · UNKNOWN

Trial details

NCT number: NCT03222167
Sponsor: Institute Of Cardiology & Internal Diseases, Kazakhstan
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis C Genotype 1B Metabolic Syndrome Fibrosis, Liver Cirrhoses, Liver

Start date: 2017-10-01
Primary completion: 2019-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.